NO20054714L - Fremgangsmate for behandling av svake kognitive svekkelser, og for a forhindre eller utsette Alzheimers sykdom - Google Patents
Fremgangsmate for behandling av svake kognitive svekkelser, og for a forhindre eller utsette Alzheimers sykdomInfo
- Publication number
- NO20054714L NO20054714L NO20054714A NO20054714A NO20054714L NO 20054714 L NO20054714 L NO 20054714L NO 20054714 A NO20054714 A NO 20054714A NO 20054714 A NO20054714 A NO 20054714A NO 20054714 L NO20054714 L NO 20054714L
- Authority
- NO
- Norway
- Prior art keywords
- disease
- procedures
- preventing
- cognitive impairments
- alzheimer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Det er beskrevet anvendelse av en forbindelse av formel I eller et farmasøytisk akseptabelt salt derav, for fremstilling av et medikament for behandling av aldersrelatert kognitivt forfall eller mild kognitiv svekkelse, i særdeleshet for å forhindre eller forsinke starten av Alzheimers sykdom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45458903P | 2003-03-14 | 2003-03-14 | |
PCT/GB2004/000983 WO2004080459A1 (en) | 2003-03-14 | 2004-03-08 | Method for treating mild cognitive impairment and for preventing or delaying alzheimer’s disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054714D0 NO20054714D0 (no) | 2005-10-13 |
NO20054714L true NO20054714L (no) | 2005-11-16 |
Family
ID=32990914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054714A NO20054714L (no) | 2003-03-14 | 2005-10-13 | Fremgangsmate for behandling av svake kognitive svekkelser, og for a forhindre eller utsette Alzheimers sykdom |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060241133A1 (no) |
EP (1) | EP1605940A1 (no) |
JP (1) | JP2006520371A (no) |
KR (1) | KR20050109990A (no) |
CN (1) | CN1794992A (no) |
AU (1) | AU2004218871A1 (no) |
BR (1) | BRPI0408295A (no) |
CA (1) | CA2518886A1 (no) |
IS (1) | IS8004A (no) |
MX (1) | MXPA05009850A (no) |
NO (1) | NO20054714L (no) |
RU (1) | RU2005131845A (no) |
WO (1) | WO2004080459A1 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0313772D0 (en) * | 2003-06-13 | 2003-07-23 | Merck Sharp & Dohme | Therapeutic treatment |
US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
US7838676B2 (en) * | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
US7872009B2 (en) | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
WO2007061670A1 (en) | 2005-11-21 | 2007-05-31 | Amgen Inc. | Beta-secretase modulators and methods of use |
US8163909B2 (en) | 2007-05-25 | 2012-04-24 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
MX2009012608A (es) | 2007-05-25 | 2009-12-07 | Amgen Inc | Compuestos de hidroxietil amina substituidos como moduladores de beta-secretasa y metodos de uso. |
US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
MY148558A (en) * | 2008-09-11 | 2013-04-30 | Amgen Inc | Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use |
WO2011063272A1 (en) | 2009-11-23 | 2011-05-26 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
WO2011063233A1 (en) | 2009-11-23 | 2011-05-26 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
AU2011207679B2 (en) | 2010-01-19 | 2013-10-10 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
CA2791281A1 (en) | 2010-03-15 | 2011-09-22 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta-secretase modulators |
EP2547686B1 (en) | 2010-03-15 | 2014-01-22 | Amgen Inc. | Amino-dihydrooxazine and amino-dihydrothiazine spiro compounds as beta-secretase modulators and their medical use |
EP2673279A1 (en) | 2011-02-07 | 2013-12-18 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
WO2013044092A1 (en) | 2011-09-21 | 2013-03-28 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
WO2014078314A1 (en) | 2012-11-15 | 2014-05-22 | Amgen Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
LU92126B1 (fr) * | 2012-12-31 | 2014-07-01 | Cesa Alliance Sa | Composé pharmaceutique pour la prévention et le traitement d'un trouble ou d'une maladie de la mémoire, neurodégénérative ou neuronale |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902680A (en) * | 1984-10-29 | 1990-02-20 | Chaovanee Aroonsakul | Treating central nervous system diseases |
PL176993B1 (pl) * | 1992-12-11 | 1999-08-31 | Merck & Co Inc | Nowe związki spiropiperydynowe oraz sposób ich wytwarzania |
WO1996033189A1 (en) * | 1995-04-19 | 1996-10-24 | Merck & Co., Inc. | Process for the preparation of spiroindolines |
US5767124A (en) * | 1995-10-27 | 1998-06-16 | Merck & Co., Inc. | Polymorphic forms of a growth hormone secretagogue |
US6028196A (en) * | 1995-10-27 | 2000-02-22 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
EP0900086A4 (en) * | 1996-05-07 | 2000-01-12 | Merck & Co Inc | IMPROVING THE SLEEP BY MEANS OF A SUBSTANCE PROMOTING THE SECRETION OF GROWTH HORMONES |
US6046333A (en) * | 1996-10-25 | 2000-04-04 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
WO2000013650A2 (en) * | 1998-09-03 | 2000-03-16 | Neuronz Limited | Neuroprotection |
ATE304373T1 (de) * | 1999-12-28 | 2005-09-15 | Kaken Pharma Co Ltd | Nervenschutzmittel |
EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
-
2004
- 2004-03-08 JP JP2006505929A patent/JP2006520371A/ja not_active Withdrawn
- 2004-03-08 MX MXPA05009850A patent/MXPA05009850A/es unknown
- 2004-03-08 CN CNA2004800069622A patent/CN1794992A/zh active Pending
- 2004-03-08 CA CA002518886A patent/CA2518886A1/en not_active Abandoned
- 2004-03-08 BR BRPI0408295-8A patent/BRPI0408295A/pt not_active Application Discontinuation
- 2004-03-08 WO PCT/GB2004/000983 patent/WO2004080459A1/en not_active Application Discontinuation
- 2004-03-08 EP EP04718341A patent/EP1605940A1/en not_active Withdrawn
- 2004-03-08 RU RU2005131845/15A patent/RU2005131845A/ru not_active Application Discontinuation
- 2004-03-08 US US10/549,839 patent/US20060241133A1/en not_active Abandoned
- 2004-03-08 KR KR1020057017128A patent/KR20050109990A/ko not_active Application Discontinuation
- 2004-03-08 AU AU2004218871A patent/AU2004218871A1/en not_active Abandoned
-
2005
- 2005-08-29 IS IS8004A patent/IS8004A/is unknown
- 2005-10-13 NO NO20054714A patent/NO20054714L/no unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA05009850A (es) | 2005-12-06 |
WO2004080459A1 (en) | 2004-09-23 |
AU2004218871A1 (en) | 2004-09-23 |
IS8004A (is) | 2005-08-29 |
NO20054714D0 (no) | 2005-10-13 |
KR20050109990A (ko) | 2005-11-22 |
CA2518886A1 (en) | 2004-09-23 |
JP2006520371A (ja) | 2006-09-07 |
BRPI0408295A (pt) | 2006-03-07 |
RU2005131845A (ru) | 2006-02-10 |
EP1605940A1 (en) | 2005-12-21 |
US20060241133A1 (en) | 2006-10-26 |
CN1794992A (zh) | 2006-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054714L (no) | Fremgangsmate for behandling av svake kognitive svekkelser, og for a forhindre eller utsette Alzheimers sykdom | |
NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
GB0225475D0 (en) | Therapeutic agents | |
GB0005251D0 (en) | Therapeutic compounds | |
IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
GB0223038D0 (en) | Therapeutic compounds | |
EA200400881A1 (ru) | Азаарилпиперазины | |
SE0202462D0 (sv) | Novel use | |
GB0318447D0 (en) | Therapeutic agents | |
ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
JO2282B1 (en) | Oxazole derivatives | |
GB0225474D0 (en) | Therapeutic agents | |
MXPA05010958A (es) | Derivados indazol como inhibidores jnk. | |
WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
WO2004029031A3 (en) | Therapeutic piperazine compounds | |
ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
NO20044475L (no) | 2-(2,6-diklorfenyl)-diarulimidazoler | |
GB0112348D0 (en) | Compounds | |
EA200401114A3 (ru) | Замещённые гидроксиэтиламины | |
SE0202429D0 (sv) | Novel Compounds | |
UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
NO20052698L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser. | |
NO20065079L (no) | Materialer og metoder for behandling av koaguleringssykdommer | |
ATE451922T1 (de) | Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren |